Purification and Characterization of a Novel Proline-directed Protein Kinase from Bovine Brain
Overview
Authors
Affiliations
A novel protein kinase which phosphorylates a synthetic peptide substrate (RRPDAHRTPNRAF) has been purified approximately 200,000-fold from bovine brain. This peptide contains the consensus sequence for phosphorylation by the p34cdc2 kinase. The purification procedure took advantage of the phenomenon that this novel brain kinase, in partially purified extracts, chromatographed on a gel filtration column as a high molecular weight complex which dissociated in buffer containing 1 M NaCl. The purified native enzyme was estimated to be approximately 63,000, and displayed two bands of M(r) = 33,000 and 25,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. On Western immunoblot, the M(r) = 33,000 peptide reacted strongly with antibodies specific for a conserved amino-terminal sequence, weakly with antibodies to the conserved PSTAIRE sequence, and not at all with antibodies to the carboxyl terminus, of HeLa cell p34cdc2. The brain kinase and p34cdc2 were similar in displaying good activity toward the parent peptide substrate, but no activity toward peptide analogues in which the -T-P- motif was substituted with either -T-G- or -T-A-. Both kinases showed marked preference in phosphorylating a peptide derived from H1 histone (KTPKKAKKPKTPKKAKKL), and both kinases could be phosphorylated by the src-family tyrosine kinase, p56lyn, purified from bovine spleen. However, the brain kinase did not co-purify with a subunit having a molecular weight corresponding to known cyclins, nor did it undergo specific interaction with p13suc1 beads, suggesting that this enzyme is distinct from p34cdc2.
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease.
Pellarin I, DallAcqua A, Favero A, Segatto I, Rossi V, Crestan N Signal Transduct Target Ther. 2025; 10(1):11.
PMID: 39800748 PMC: 11734941. DOI: 10.1038/s41392-024-02080-z.
Hall B, Amin N, Veeranna , Hisanaga S, Kulkarni A Neurochem Res. 2024; 49(12):3181-3186.
PMID: 39235580 PMC: 11502590. DOI: 10.1007/s11064-024-04234-5.
Cyclin-dependent Kinase 5 and Neurodegenerative Diseases.
Song M, Qiang Y, Zhao X, Song F Mol Neurobiol. 2024; 61(10):7287-7302.
PMID: 38378992 DOI: 10.1007/s12035-024-04047-1.
CDK5: an oncogene or an anti-oncogene: location location location.
Nikhil K, Shah K Mol Cancer. 2023; 22(1):186.
PMID: 37993880 PMC: 10666462. DOI: 10.1186/s12943-023-01895-8.
Sharma A, Rahman G, Gorelik J, Bhargava A Cells. 2023; 12(3).
PMID: 36766802 PMC: 9913649. DOI: 10.3390/cells12030461.